Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19

Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19

<p><strong>Background</strong></p> Thrombosis and inflammation may contribute to the risk of death and complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation may improve outcomes in noncritically ill patien...

Full description

Bibliographic Details
Main Authors:	Lawler, PR, Goligher, EC, Berger, JS, Beane, A, Estcourt, LJ, Haniffa, R, Stanworth, SJ
Other Authors:	ATTACC Investigators
Format:	Journal article
Language:	English
Published:	Massachusetts Medical Society 2021

Similar Items

Therapeutic anticoagulation with heparin in critically ill patients with Covid-19
by: Goligher, EC, et al.
Published: (2021)

Continuation of therapeutic dose heparin for critically ill patients with COVID-19
by: Bradbury, CA, et al.
Published: (2023)

Anticoagulation is the answer in treating noncritical COVID-19 patients
by: Kabir Azad A.
Published: (2021-10-01)

Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation
by: Francesco Poletto, et al.
Published: (2022-03-01)

On supergravity and noncritical strings
by: Andrea Dei, et al.
Published: (2025-01-01)

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support–free days in patients hospitalized with COVID-19: a randomized clinical trial
by: Lawler, PR, et al.
Published: (2023)

Parenteral Nutrition-Associated Hyperglycemia in Noncritically Ill Inpatients Is Associated with Higher Mortality
by: Sofia Sarkisian, et al.
Published: (2010-01-01)

Role of the Bronchoalveolar Lavage in Noncritically Ill Patients during the SARS-CoV-2 Epidemic
by: Olivier Taton, et al.
Published: (2020-01-01)

A local induced action for the noncritical string
by: Westra, W, et al.
Published: (2011)

Standing waves for Choquard equation with noncritical rotation
by: Mao Yicen, et al.
Published: (2024-06-01)

Dangers of Noncritical Use of Historical Plague Data
by: Joris Roosen, et al.
Published: (2018-01-01)

Telehealth for Noncritical Patients With Chronic Diseases During the COVID-19 Pandemic
by: Liu, Na, et al.
Published: (2020-08-01)

Interleukin-6 receptor antagonists in critically ill patients with Covid-19
by: Gordon, AC, et al.
Published: (2021)

Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non‐cardiac surgery or invasive procedures
by: Huber, J, et al.
Published: (2018)

Appropriateness of proton pump inhibitors use in noncritically ill hospitalized children in a tertiary hospital in Saudi Arabia
by: Yousif A. Alosaily, et al.
Published: (2023-09-01)

Optimal systolic blood pressure in noncritically ill patients with acute kidney injury: A retrospective cohort study
by: Seon Ha Baek, et al.
Published: (2019-09-01)

How to assess hypercoagulability in heparin-induced thrombocytopenia? Biomarkers of potential value to support therapeutic intensity of non-heparin anticoagulation
by: Antoine Barocas, et al.
Published: (2023-09-01)

Heparin anticoagulation versus regional citrate anticoagulation for membrane therapeutic plasma exchange in patients with increased bleeding risk
by: Jing Jiao, et al.
Published: (2023-12-01)

Evaluation of an algorithm for intensive subcutaneous insulin therapy in noncritically ill hospitalised patients with hyperglycaemia in a randomised controlled trial
by: Robert Thomann, et al.
Published: (2013-06-01)

Intravenous fluid therapy in the noncritically ill patient. Our experience at a tertiary care emergency department in Abu Dhabi
by: Bashar Elwir, et al.
Published: (2020-06-01)

Therapeutic Anticoagulation with Argatroban and Heparins Reduces Granulocyte Migration: Possible Impact on ECLS-Therapy?
by: Andre Bredthauer, et al.
Published: (2020-01-01)

Key patient demographics shape innate immune topography in noncritical hypoxic COVID-19 pneumonia
by: Allison C. Billi, et al.
Published: (2023-08-01)

The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19
by: Heloísa Antoniella Braz-de-Melo, et al.
Published: (2021-04-01)

Regional citrate anticoagulation versus systemic heparin anticoagulation for continuous kidney replacement therapy in intensive care
by: Doidge, JC, et al.
Published: (2022)

A linear programming approach to maximize savings by stretching noncritical activities.
by: Khalaf, Wakas S., et al.
Published: (2010)

Not Just Anticoagulation—New and Old Applications of Heparin
by: Lixuan Zang, et al.
Published: (2022-10-01)

Spontaneous Breast Haematoma after Heparin Anticoagulation
by: Imran Yaseen Gani, et al.
Published: (2020-06-01)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Russian Translation of Cochrane Plain Language Summary)
by: Crighton, GL, et al.
Published: (2021)

Venous Thromboembolism in Hospitalized Critical and Noncritical COVID-19 Patients: A Systematic Review and Meta-analysis
by: Eman M. Mansory, et al.
Published: (2021-07-01)

Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients
by: Baranca Buijsers, et al.
Published: (2020-09-01)

Study on electric spring control method considering noncritical load voltage constraint
by: Yixi Chen, et al.
Published: (2018-11-01)

Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia
by: Romanová T, et al.
Published: (2024-09-01)

Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins
by: V. O. Bitsadze, et al.
Published: (2021-07-01)

Multifaceted Heparin: Diverse Applications beyond Anticoagulant Therapy
by: Razia Sultana, et al.
Published: (2024-10-01)

Preparation, Anticoagulant and Antioxidant Properties of Glucosamine-Heparin Salt
by: Qin Miao, et al.
Published: (2022-10-01)

Non-Anticoagulant Heparins Are Hepcidin Antagonists for the Treatment of Anemia
by: Maura Poli, et al.
Published: (2017-04-01)

Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease
by: Janis Kay Shute
Published: (2023-04-01)

Effect of antiplatelet therapy on survival and organ support-free days in critically ill patients with COVID-19: a randomized clinical trial
by: Bradbury, CA, et al.
Published: (2022)

Sex-Specific Total Testosterone and Dehydroepiandrosterone Sulfate Status in Noncritically Ill Hospitalized Patients with Coronavirus Disease 2019: A Cross-Sectional Study
by: Hurjahan Banu, et al.
Published: (2024-01-01)

Outcomes in acute kidney injury in noncritically ill patients lately referred to nephrologist in a developing country: a comparison of AKIN and KDIGO criteria
by: Ginivaldo Victor Ribeiro do Nascimento, et al.
Published: (2020-03-01)